Luca Scavo - 01 Jun 2021 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
CFO
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Luca Scavo
Issuer symbol
EVLO on OTC
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
03 Jun 2021, 16:49:43 UTC
Next filing
21 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +300,000 $0.000000 300,000 01 Jun 2021 Common Stock 300,000 $14.24 Direct F1
transaction EVLO Restricted Stock Units Award $0 +4,545 $0.000000 4,545 01 Jun 2021 Common Stock 4,545 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of underlying shares will vest on 1st anniversary of employment commencement date (i.e., June 1, 2022), and remaining 75% of underlying shares will vest in 36 substantially equal monthly installments thereafter
F2 These options will vest 100% on 3rd anniversary of employment commencement date (i.e., June 1, 2024)